has received expanded approval from the FDA for adults with moderately-to-severely-active ulcerative colitis. It is the first oral medication approved for chronic use in this indication ...

Ulcerative colitis medications help control the symptoms of ulcerative colitis (UC) and prevent flare-ups or relapses. UC is a chronic inflammatory bowel disease. It's an autoimmune condition ...

has an anti-inflammatory effect in the colon and is a suitable treatment for ulcerative colitis. Guiseppe Celasco and his colleagues did a double-blind, randomized, placebo-controlled phase IIa ...

The persistent inflammation results in the damage and ultimately the symptoms of ulcerative colitis. Most medications for ulcerative colitis work by decreasing or "turning down," the immune system to ...

Over 80% of patients maintained endoscopic response after two years of continuous Omvoh treatment in ongoing studies ...

Crohn’s disease and ulcerative colitis (UC) are both types of inflammatory bowel disease (IBD) that share similar symptoms but differ in their affected areas, disease progression, and treatment ...

Unfortunately, ulcerative colitis can occur in anyone, including pregnant women. But that does not mean you do not plan for a family. With proper management and treatment, women can experience a ...

The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...

The direct cause of the disease is unknown, but patients are commonly treated with anti-inflammatory drugs. Patients with refractory ulcerative colitis often undergo ileal pouch anal anastomosis ...

Ulcerative Colitis companies are Janssen Pharmaceuticals, Takeda Pharmaceuticals, Pfizer, EA Pharma, Kissei Pharma, Gilead Sciences, Galapagos NV, Celgene (Bristol-Myers Squibb), AbbVie, Arena ...